Study of NNZ-2566 in Patients With Traumatic Brain Injury Under EFIC (INTREPID2566)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01366820
Recruitment Status : Completed
First Posted : June 6, 2011
Last Update Posted : February 5, 2018
Information provided by (Responsible Party):
Neuren Pharmaceuticals Limited

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : January 2016
  Actual Study Completion Date : January 2016
  Certification/Extension First Submitted : January 31, 2018